nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—breast cancer—bone cancer	0.469	1	CtDrD
Tamoxifen—DHCR7—Epirubicin—bone cancer	0.143	0.434	CbGbCtD
Tamoxifen—CYP3A4—bone cancer	0.0989	1	CbGaD
Tamoxifen—DHCR7—Doxorubicin—bone cancer	0.0758	0.231	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—bone cancer	0.012	0.0366	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—bone cancer	0.012	0.0366	CbGbCtD
Tamoxifen—ABCC2—Carboplatin—bone cancer	0.011	0.0336	CbGbCtD
Tamoxifen—ABCG2—Carboplatin—bone cancer	0.00997	0.0304	CbGbCtD
Tamoxifen—ABCC2—Cisplatin—bone cancer	0.00942	0.0287	CbGbCtD
Tamoxifen—ABCG2—Cisplatin—bone cancer	0.00852	0.0259	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—bone cancer	0.00631	0.0192	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—bone cancer	0.00612	0.0186	CbGbCtD
Tamoxifen—CYP2B6—Cisplatin—bone cancer	0.00599	0.0182	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—bone cancer	0.00571	0.0174	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—bone cancer	0.00553	0.0168	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—bone cancer	0.00401	0.0122	CbGbCtD
Tamoxifen—CYP2C9—Cisplatin—bone cancer	0.00316	0.00964	CbGbCtD
Tamoxifen—ABCB1—Cisplatin—bone cancer	0.00307	0.00935	CbGbCtD
Tamoxifen—ABCB1—Doxorubicin—bone cancer	0.00206	0.00627	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—bone cancer	0.00199	0.00607	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—bone cancer	0.00194	0.00591	CbGbCtD
Tamoxifen—CYP3A4—Doxorubicin—bone cancer	0.00123	0.00376	CbGbCtD
Tamoxifen—Bedaquiline—CYP3A4—bone cancer	0.000336	0.211	CrCbGaD
Tamoxifen—Diethylstilbestrol—CYP3A4—bone cancer	0.000173	0.109	CrCbGaD
Tamoxifen—Ospemifene—CYP3A4—bone cancer	0.000169	0.106	CrCbGaD
Tamoxifen—Toremifene—CYP3A4—bone cancer	0.000137	0.0861	CrCbGaD
Tamoxifen—Cramps of lower extremities—Epirubicin—bone cancer	0.000122	0.00238	CcSEcCtD
Tamoxifen—Flushing—Cisplatin—bone cancer	0.000121	0.00235	CcSEcCtD
Tamoxifen—Neoplasm—Epirubicin—bone cancer	0.00012	0.00234	CcSEcCtD
Tamoxifen—Clomifene—CYP3A4—bone cancer	0.000119	0.0744	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP3A4—bone cancer	0.000119	0.0744	CrCbGaD
Tamoxifen—Skin exfoliation—Doxorubicin—bone cancer	0.000118	0.00229	CcSEcCtD
Tamoxifen—Fluid retention—Doxorubicin—bone cancer	0.000117	0.00228	CcSEcCtD
Tamoxifen—Arrhythmia—Cisplatin—bone cancer	0.000116	0.00227	CcSEcCtD
Tamoxifen—Vaginal infection—Doxorubicin—bone cancer	0.000116	0.00227	CcSEcCtD
Tamoxifen—Sepsis—Epirubicin—bone cancer	0.000116	0.00225	CcSEcCtD
Tamoxifen—Alopecia—Cisplatin—bone cancer	0.000115	0.00224	CcSEcCtD
Tamoxifen—Hepatic failure—Methotrexate—bone cancer	0.000115	0.00224	CcSEcCtD
Tamoxifen—Erythema—Cisplatin—bone cancer	0.000113	0.00221	CcSEcCtD
Tamoxifen—Cramps of lower extremities—Doxorubicin—bone cancer	0.000113	0.0022	CcSEcCtD
Tamoxifen—Neoplasm—Doxorubicin—bone cancer	0.000111	0.00217	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Epirubicin—bone cancer	0.000111	0.00215	CcSEcCtD
Tamoxifen—Visual disturbance—Methotrexate—bone cancer	0.000109	0.00212	CcSEcCtD
Tamoxifen—Muscle spasms—Cisplatin—bone cancer	0.000109	0.00212	CcSEcCtD
Tamoxifen—Hepatic failure—Epirubicin—bone cancer	0.000108	0.00209	CcSEcCtD
Tamoxifen—Sepsis—Doxorubicin—bone cancer	0.000107	0.00208	CcSEcCtD
Tamoxifen—Anaemia—Cisplatin—bone cancer	0.000105	0.00204	CcSEcCtD
Tamoxifen—Hot flush—Epirubicin—bone cancer	0.000103	0.00201	CcSEcCtD
Tamoxifen—Osteoarthritis—Methotrexate—bone cancer	0.000103	0.00201	CcSEcCtD
Tamoxifen—Menopausal symptoms—Epirubicin—bone cancer	0.000102	0.00199	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Doxorubicin—bone cancer	0.000102	0.00199	CcSEcCtD
Tamoxifen—Leukopenia—Cisplatin—bone cancer	0.000101	0.00198	CcSEcCtD
Tamoxifen—Dermatitis bullous—Epirubicin—bone cancer	0.000101	0.00197	CcSEcCtD
Tamoxifen—Hepatic failure—Doxorubicin—bone cancer	9.96e-05	0.00194	CcSEcCtD
Tamoxifen—Mood swings—Methotrexate—bone cancer	9.79e-05	0.00191	CcSEcCtD
Tamoxifen—Osteoarthritis—Epirubicin—bone cancer	9.67e-05	0.00188	CcSEcCtD
Tamoxifen—Myalgia—Cisplatin—bone cancer	9.65e-05	0.00188	CcSEcCtD
Tamoxifen—Anxiety—Cisplatin—bone cancer	9.62e-05	0.00187	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—bone cancer	9.56e-05	0.00186	CcSEcCtD
Tamoxifen—Liver function test abnormal—Methotrexate—bone cancer	9.54e-05	0.00186	CcSEcCtD
Tamoxifen—Discomfort—Cisplatin—bone cancer	9.54e-05	0.00186	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—bone cancer	9.48e-05	0.00185	CcSEcCtD
Tamoxifen—Dermatitis bullous—Doxorubicin—bone cancer	9.36e-05	0.00182	CcSEcCtD
Tamoxifen—Levomethadyl Acetate—CYP3A4—bone cancer	9.28e-05	0.0581	CrCbGaD
Tamoxifen—Oedema—Cisplatin—bone cancer	9.25e-05	0.0018	CcSEcCtD
Tamoxifen—Infection—Cisplatin—bone cancer	9.19e-05	0.00179	CcSEcCtD
Tamoxifen—Mood swings—Epirubicin—bone cancer	9.16e-05	0.00178	CcSEcCtD
Tamoxifen—Thrombocytopenia—Cisplatin—bone cancer	9.06e-05	0.00176	CcSEcCtD
Tamoxifen—Blood creatinine increased—Epirubicin—bone cancer	9.06e-05	0.00176	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—bone cancer	8.95e-05	0.00174	CcSEcCtD
Tamoxifen—Hyperhidrosis—Cisplatin—bone cancer	8.95e-05	0.00174	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—bone cancer	8.93e-05	0.00174	CcSEcCtD
Tamoxifen—Anorexia—Cisplatin—bone cancer	8.82e-05	0.00172	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—bone cancer	8.76e-05	0.0017	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—bone cancer	8.71e-05	0.0017	CcSEcCtD
Tamoxifen—Abdominal discomfort—Methotrexate—bone cancer	8.56e-05	0.00167	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—bone cancer	8.53e-05	0.00166	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—bone cancer	8.48e-05	0.00165	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—bone cancer	8.48e-05	0.00165	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Cisplatin—bone cancer	8.43e-05	0.00164	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—bone cancer	8.38e-05	0.00163	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—bone cancer	8.36e-05	0.00163	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—bone cancer	8.36e-05	0.00163	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—bone cancer	8.35e-05	0.00163	CcSEcCtD
Tamoxifen—Paraesthesia—Cisplatin—bone cancer	8.31e-05	0.00162	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—bone cancer	8.26e-05	0.00161	CcSEcCtD
Tamoxifen—Dyspnoea—Cisplatin—bone cancer	8.25e-05	0.00161	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—bone cancer	8.22e-05	0.0016	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—bone cancer	8.19e-05	0.0016	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—bone cancer	8.14e-05	0.00158	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—bone cancer	8.06e-05	0.00157	CcSEcCtD
Tamoxifen—Decreased appetite—Cisplatin—bone cancer	8.04e-05	0.00157	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—bone cancer	8.04e-05	0.00156	CcSEcCtD
Tamoxifen—Dextropropoxyphene—CYP3A4—bone cancer	8.02e-05	0.0502	CrCbGaD
Tamoxifen—Pneumonia—Methotrexate—bone cancer	8.01e-05	0.00156	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Cisplatin—bone cancer	7.99e-05	0.00156	CcSEcCtD
Tamoxifen—Depression—Methotrexate—bone cancer	7.94e-05	0.00155	CcSEcCtD
Tamoxifen—Pancytopenia—Epirubicin—bone cancer	7.94e-05	0.00155	CcSEcCtD
Tamoxifen—Pain—Cisplatin—bone cancer	7.91e-05	0.00154	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—bone cancer	7.89e-05	0.00154	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—bone cancer	7.89e-05	0.00154	CcSEcCtD
Tamoxifen—Neutropenia—Epirubicin—bone cancer	7.81e-05	0.00152	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—bone cancer	7.73e-05	0.00151	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—bone cancer	7.73e-05	0.00151	CcSEcCtD
Tamoxifen—Loperamide—CYP3A4—bone cancer	7.64e-05	0.0479	CrCbGaD
Tamoxifen—Sweating—Methotrexate—bone cancer	7.63e-05	0.00149	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—bone cancer	7.61e-05	0.00148	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—bone cancer	7.58e-05	0.00148	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—bone cancer	7.56e-05	0.00147	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—bone cancer	7.53e-05	0.00147	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—bone cancer	7.49e-05	0.00146	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—bone cancer	7.44e-05	0.00145	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—bone cancer	7.39e-05	0.00144	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—bone cancer	7.34e-05	0.00143	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—bone cancer	7.24e-05	0.00141	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—bone cancer	7.23e-05	0.00141	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—bone cancer	7.18e-05	0.0014	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—bone cancer	7.15e-05	0.00139	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—bone cancer	7.15e-05	0.00139	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—bone cancer	7.14e-05	0.00139	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—bone cancer	7.09e-05	0.00138	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—bone cancer	7.04e-05	0.00137	CcSEcCtD
Tamoxifen—Benzphetamine—CYP3A4—bone cancer	7.04e-05	0.0441	CrCbGaD
Tamoxifen—Weight decreased—Doxorubicin—bone cancer	7e-05	0.00136	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—bone cancer	6.99e-05	0.00136	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—bone cancer	6.93e-05	0.00135	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—bone cancer	6.89e-05	0.00134	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—bone cancer	6.84e-05	0.00133	CcSEcCtD
Tamoxifen—Hypersensitivity—Cisplatin—bone cancer	6.82e-05	0.00133	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—bone cancer	6.76e-05	0.00132	CcSEcCtD
Tamoxifen—Phenoxybenzamine—CYP3A4—bone cancer	6.72e-05	0.0421	CrCbGaD
Tamoxifen—Haemoglobin—Epirubicin—bone cancer	6.72e-05	0.00131	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—bone cancer	6.7e-05	0.0013	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—bone cancer	6.69e-05	0.0013	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—bone cancer	6.69e-05	0.0013	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—bone cancer	6.66e-05	0.0013	CcSEcCtD
Tamoxifen—Asthenia—Cisplatin—bone cancer	6.64e-05	0.00129	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—bone cancer	6.64e-05	0.00129	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—bone cancer	6.61e-05	0.00129	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—bone cancer	6.59e-05	0.00128	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—bone cancer	6.47e-05	0.00126	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—bone cancer	6.45e-05	0.00125	CcSEcCtD
Tamoxifen—Diarrhoea—Cisplatin—bone cancer	6.33e-05	0.00123	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—bone cancer	6.32e-05	0.00123	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—bone cancer	6.32e-05	0.00123	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—bone cancer	6.22e-05	0.00121	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—bone cancer	6.22e-05	0.00121	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—bone cancer	6.21e-05	0.00121	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—bone cancer	6.19e-05	0.0012	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—bone cancer	6.19e-05	0.0012	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—bone cancer	6.16e-05	0.0012	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—bone cancer	6.14e-05	0.0012	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—bone cancer	6.1e-05	0.00119	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—bone cancer	6.09e-05	0.00119	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—bone cancer	6.02e-05	0.00117	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—bone cancer	5.98e-05	0.00116	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—bone cancer	5.96e-05	0.00116	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—bone cancer	5.91e-05	0.00115	CcSEcCtD
Tamoxifen—Vomiting—Cisplatin—bone cancer	5.88e-05	0.00115	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—bone cancer	5.85e-05	0.00114	CcSEcCtD
Tamoxifen—Rash—Cisplatin—bone cancer	5.83e-05	0.00114	CcSEcCtD
Tamoxifen—Dermatitis—Cisplatin—bone cancer	5.83e-05	0.00113	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—bone cancer	5.82e-05	0.00113	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—bone cancer	5.75e-05	0.00112	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—bone cancer	5.74e-05	0.00112	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—bone cancer	5.7e-05	0.00111	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—bone cancer	5.63e-05	0.0011	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—bone cancer	5.6e-05	0.00109	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—bone cancer	5.57e-05	0.00108	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—bone cancer	5.53e-05	0.00108	CcSEcCtD
Tamoxifen—Nausea—Cisplatin—bone cancer	5.5e-05	0.00107	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—bone cancer	5.47e-05	0.00106	CcSEcCtD
Tamoxifen—Methadone—CYP3A4—bone cancer	5.44e-05	0.0341	CrCbGaD
Tamoxifen—Cough—Methotrexate—bone cancer	5.43e-05	0.00106	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—bone cancer	5.39e-05	0.00105	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—bone cancer	5.38e-05	0.00105	CcSEcCtD
Tamoxifen—Orphenadrine—CYP3A4—bone cancer	5.33e-05	0.0334	CrCbGaD
Tamoxifen—Arthralgia—Methotrexate—bone cancer	5.3e-05	0.00103	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—bone cancer	5.3e-05	0.00103	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—bone cancer	5.3e-05	0.00103	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—bone cancer	5.28e-05	0.00103	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—bone cancer	5.23e-05	0.00102	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—bone cancer	5.21e-05	0.00101	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—bone cancer	5.21e-05	0.00101	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—bone cancer	5.18e-05	0.00101	CcSEcCtD
Tamoxifen—Cough—Epirubicin—bone cancer	5.08e-05	0.000989	CcSEcCtD
Tamoxifen—Infection—Methotrexate—bone cancer	5.05e-05	0.000982	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—bone cancer	5.03e-05	0.000979	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—bone cancer	4.98e-05	0.000969	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—bone cancer	4.97e-05	0.000968	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—bone cancer	4.96e-05	0.000965	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—bone cancer	4.96e-05	0.000965	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—bone cancer	4.96e-05	0.000965	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—bone cancer	4.94e-05	0.000962	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—bone cancer	4.91e-05	0.000956	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—bone cancer	4.9e-05	0.000954	CcSEcCtD
Tamoxifen—Promazine—CYP3A4—bone cancer	4.86e-05	0.0305	CrCbGaD
Tamoxifen—Dry mouth—Epirubicin—bone cancer	4.85e-05	0.000944	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—bone cancer	4.84e-05	0.000942	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—bone cancer	4.82e-05	0.000939	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—bone cancer	4.75e-05	0.000925	CcSEcCtD
Tamoxifen—Infection—Epirubicin—bone cancer	4.72e-05	0.000919	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—bone cancer	4.7e-05	0.000915	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—bone cancer	4.65e-05	0.000906	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—bone cancer	4.65e-05	0.000906	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—bone cancer	4.63e-05	0.000901	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—bone cancer	4.59e-05	0.000894	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—bone cancer	4.59e-05	0.000894	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—bone cancer	4.59e-05	0.000893	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—bone cancer	4.59e-05	0.000893	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—bone cancer	4.59e-05	0.000893	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—bone cancer	4.57e-05	0.00089	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—bone cancer	4.56e-05	0.000888	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—bone cancer	4.53e-05	0.000882	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—bone cancer	4.53e-05	0.000882	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—bone cancer	4.53e-05	0.000881	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—bone cancer	4.49e-05	0.000873	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—bone cancer	4.47e-05	0.00087	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—bone cancer	4.41e-05	0.000859	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—bone cancer	4.4e-05	0.000856	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—bone cancer	4.38e-05	0.000854	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—bone cancer	4.38e-05	0.000852	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—bone cancer	4.37e-05	0.00085	CcSEcCtD
Tamoxifen—Pain—Methotrexate—bone cancer	4.34e-05	0.000845	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—bone cancer	4.33e-05	0.000843	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—bone cancer	4.31e-05	0.000838	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—bone cancer	4.3e-05	0.000837	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—bone cancer	4.27e-05	0.000831	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—bone cancer	4.25e-05	0.000828	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—bone cancer	4.24e-05	0.000825	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—bone cancer	4.19e-05	0.000816	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—bone cancer	4.18e-05	0.000814	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—bone cancer	4.15e-05	0.000808	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—bone cancer	4.13e-05	0.000804	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—bone cancer	4.1e-05	0.000799	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—bone cancer	4.1e-05	0.000798	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—bone cancer	4.06e-05	0.000791	CcSEcCtD
Tamoxifen—Pain—Epirubicin—bone cancer	4.06e-05	0.000791	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—bone cancer	4.03e-05	0.000785	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—bone cancer	4.01e-05	0.000782	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.01e-05	0.00078	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—bone cancer	3.98e-05	0.000774	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—bone cancer	3.95e-05	0.000769	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—bone cancer	3.92e-05	0.000763	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—bone cancer	3.89e-05	0.000757	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—bone cancer	3.87e-05	0.000754	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—bone cancer	3.82e-05	0.000744	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—bone cancer	3.8e-05	0.000739	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—bone cancer	3.79e-05	0.000738	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—bone cancer	3.78e-05	0.000735	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—bone cancer	3.76e-05	0.000732	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—bone cancer	3.76e-05	0.000732	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—bone cancer	3.76e-05	0.000731	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—bone cancer	3.74e-05	0.000728	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—bone cancer	3.64e-05	0.000709	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—bone cancer	3.6e-05	0.0007	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—bone cancer	3.59e-05	0.000699	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—bone cancer	3.5e-05	0.000682	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—bone cancer	3.49e-05	0.00068	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—bone cancer	3.48e-05	0.000677	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—bone cancer	3.47e-05	0.000676	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—bone cancer	3.41e-05	0.000664	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—bone cancer	3.36e-05	0.000655	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—bone cancer	3.36e-05	0.000654	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—bone cancer	3.25e-05	0.000633	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—bone cancer	3.24e-05	0.000631	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—bone cancer	3.23e-05	0.000629	CcSEcCtD
Tamoxifen—Rash—Methotrexate—bone cancer	3.2e-05	0.000623	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—bone cancer	3.2e-05	0.000623	CcSEcCtD
Tamoxifen—Headache—Methotrexate—bone cancer	3.18e-05	0.000619	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—bone cancer	3.15e-05	0.000614	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—bone cancer	3.14e-05	0.000612	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—bone cancer	3.11e-05	0.000606	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—bone cancer	3.02e-05	0.000588	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—bone cancer	3.02e-05	0.000587	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—bone cancer	3.01e-05	0.000586	CcSEcCtD
Tamoxifen—Rash—Epirubicin—bone cancer	3e-05	0.000583	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—bone cancer	2.99e-05	0.000583	CcSEcCtD
Tamoxifen—Headache—Epirubicin—bone cancer	2.98e-05	0.00058	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—bone cancer	2.91e-05	0.000566	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—bone cancer	2.82e-05	0.00055	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—bone cancer	2.8e-05	0.000544	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—bone cancer	2.77e-05	0.00054	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—bone cancer	2.77e-05	0.000539	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—bone cancer	2.75e-05	0.000536	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—bone cancer	2.61e-05	0.000508	CcSEcCtD
Tamoxifen—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	2.17e-05	0.000423	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GSTP1—bone cancer	2.16e-05	0.000423	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	2.16e-05	0.000421	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GNA11—bone cancer	2.15e-05	0.000421	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	2.15e-05	0.00042	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NDUFA12—bone cancer	2.15e-05	0.00042	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NDUFA12—bone cancer	2.13e-05	0.000416	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CYP3A4—bone cancer	2.1e-05	0.00041	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.1e-05	0.00041	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GSTP1—bone cancer	2.09e-05	0.000408	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.09e-05	0.000408	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	2.09e-05	0.000408	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—GSTP1—bone cancer	2.08e-05	0.000406	CbGpPWpGaD
Tamoxifen—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	2.05e-05	0.0004	CbGpPWpGaD
Tamoxifen—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	2.04e-05	0.000399	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NT5C3A—bone cancer	2.03e-05	0.000397	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—EIF2S1—bone cancer	2.02e-05	0.000395	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—FUS—bone cancer	1.99e-05	0.000389	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—CYP3A4—bone cancer	1.99e-05	0.000388	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—bone cancer	1.98e-05	0.000388	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	1.97e-05	0.000385	CbGpPWpGaD
Tamoxifen—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	1.96e-05	0.000383	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.96e-05	0.000382	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NT5C3A—bone cancer	1.96e-05	0.000382	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CYP3A4—bone cancer	1.95e-05	0.000381	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NDUFA12—bone cancer	1.95e-05	0.000381	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.94e-05	0.00038	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ENO2—bone cancer	1.91e-05	0.000373	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—GSTP1—bone cancer	1.9e-05	0.000372	CbGpPWpGaD
Tamoxifen—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	1.88e-05	0.000367	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	1.87e-05	0.000365	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—MDM2—bone cancer	1.86e-05	0.000363	CbGpPWpGaD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	1.84e-05	0.00036	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—CYP3A4—bone cancer	1.83e-05	0.000357	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.81e-05	0.000355	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—CYP3A4—bone cancer	1.81e-05	0.000354	CbGpPWpGaD
Tamoxifen—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	1.8e-05	0.000352	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GSTP1—bone cancer	1.8e-05	0.000351	CbGpPWpGaD
Tamoxifen—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	1.79e-05	0.000349	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.78e-05	0.000348	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NT5C3A—bone cancer	1.78e-05	0.000348	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.78e-05	0.000347	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—DHFR—bone cancer	1.77e-05	0.000346	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NT5C3A—bone cancer	1.77e-05	0.000345	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.76e-05	0.000344	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.76e-05	0.000344	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—EZH2—bone cancer	1.76e-05	0.000343	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—GSTP1—bone cancer	1.7e-05	0.000332	CbGpPWpGaD
Tamoxifen—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	1.68e-05	0.000327	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GSTP1—bone cancer	1.67e-05	0.000326	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.67e-05	0.000326	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GNA11—bone cancer	1.66e-05	0.000324	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.62e-05	0.000317	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NT5C3A—bone cancer	1.62e-05	0.000316	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ENO2—bone cancer	1.6e-05	0.000313	CbGpPWpGaD
Tamoxifen—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.58e-05	0.000308	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NDUFA12—bone cancer	1.58e-05	0.000308	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—GSTP1—bone cancer	1.56e-05	0.000305	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—GSTP1—bone cancer	1.55e-05	0.000303	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.55e-05	0.000303	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.55e-05	0.000302	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NDUFA12—bone cancer	1.54e-05	0.000301	CbGpPWpGaD
Tamoxifen—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	1.54e-05	0.000301	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NDUFA12—bone cancer	1.54e-05	0.000301	CbGpPWpGaD
Tamoxifen—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	1.53e-05	0.000298	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.53e-05	0.000298	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000293	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.49e-05	0.000292	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.49e-05	0.000291	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.49e-05	0.00029	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—DHFR—bone cancer	1.49e-05	0.00029	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NDUFA12—bone cancer	1.46e-05	0.000284	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.43e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.4e-05	0.000273	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.4e-05	0.000273	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GNA11—bone cancer	1.39e-05	0.000271	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—NR1I2—bone cancer	1.38e-05	0.000269	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.35e-05	0.000263	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NDUFA12—bone cancer	1.33e-05	0.000261	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.32e-05	0.000259	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NT5C3A—bone cancer	1.31e-05	0.000255	CbGpPWpGaD
Tamoxifen—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.31e-05	0.000255	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GSTP1—bone cancer	1.28e-05	0.000251	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.28e-05	0.000251	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NT5C3A—bone cancer	1.28e-05	0.00025	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.28e-05	0.00025	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NT5C3A—bone cancer	1.28e-05	0.000249	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—EGFR—bone cancer	1.27e-05	0.000248	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CYP3A4—bone cancer	1.26e-05	0.000246	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NT5C3A—bone cancer	1.21e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.2e-05	0.000234	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NDUFA12—bone cancer	1.19e-05	0.000233	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—bone cancer	1.18e-05	0.000231	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NDUFA12—bone cancer	1.16e-05	0.000227	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—bone cancer	1.14e-05	0.000223	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—bone cancer	1.12e-05	0.000219	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.11e-05	0.000216	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NT5C3A—bone cancer	1.11e-05	0.000216	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NDUFA12—bone cancer	1.1e-05	0.000214	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—DHFR—bone cancer	1.09e-05	0.000214	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NDUFA12—bone cancer	1.09e-05	0.000212	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—bone cancer	1.08e-05	0.000211	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GSTP1—bone cancer	1.08e-05	0.00021	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.07e-05	0.000209	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.06e-05	0.000207	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RGS1—bone cancer	1.03e-05	0.000202	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GRM4—bone cancer	1.03e-05	0.000202	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GNA11—bone cancer	1.02e-05	0.0002	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.02e-05	0.0002	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—EIF2S1—bone cancer	1.02e-05	0.000199	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.01e-05	0.000197	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NT5C3A—bone cancer	9.87e-06	0.000193	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NT5C3A—bone cancer	9.63e-06	0.000188	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—bone cancer	9.31e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NDUFA12—bone cancer	9.28e-06	0.000181	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CYP3A4—bone cancer	9.28e-06	0.000181	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.23e-06	0.00018	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NT5C3A—bone cancer	9.07e-06	0.000177	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NT5C3A—bone cancer	9e-06	0.000176	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GRM1—bone cancer	8.97e-06	0.000175	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—bone cancer	8.91e-06	0.000174	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	8.89e-06	0.000174	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—EZH2—bone cancer	8.85e-06	0.000173	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—bone cancer	8.65e-06	0.000169	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—bone cancer	8.58e-06	0.000168	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—DHFR—bone cancer	8.26e-06	0.000161	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	8.19e-06	0.00016	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—DHFR—bone cancer	7.96e-06	0.000155	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GSTP1—bone cancer	7.93e-06	0.000155	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	7.9e-06	0.000154	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—bone cancer	7.8e-06	0.000152	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—bone cancer	7.73e-06	0.000151	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GNA11—bone cancer	7.72e-06	0.000151	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NT5C3A—bone cancer	7.69e-06	0.00015	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GNA11—bone cancer	7.44e-06	0.000145	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—DHFR—bone cancer	7.24e-06	0.000141	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—DHFR—bone cancer	7.17e-06	0.00014	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NDUFA12—bone cancer	7.16e-06	0.00014	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	7.12e-06	0.000139	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—bone cancer	7.09e-06	0.000138	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CYP3A4—bone cancer	7e-06	0.000137	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.96e-06	0.000136	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GNA11—bone cancer	6.76e-06	0.000132	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP3A4—bone cancer	6.74e-06	0.000132	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.71e-06	0.000131	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GNA11—bone cancer	6.7e-06	0.000131	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—bone cancer	6.65e-06	0.00013	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—DHFR—bone cancer	6.58e-06	0.000128	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SMO—bone cancer	6.32e-06	0.000123	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GNA11—bone cancer	6.15e-06	0.00012	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP3A4—bone cancer	6.13e-06	0.00012	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP3A4—bone cancer	6.08e-06	0.000119	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSTP1—bone cancer	5.99e-06	0.000117	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NT5C3A—bone cancer	5.93e-06	0.000116	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GNA11—bone cancer	5.78e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSTP1—bone cancer	5.77e-06	0.000113	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—bone cancer	5.72e-06	0.000112	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—bone cancer	5.6e-06	0.000109	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	5.6e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—bone cancer	5.59e-06	0.000109	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—bone cancer	5.58e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP3A4—bone cancer	5.57e-06	0.000109	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ATF1—bone cancer	5.37e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—DHFR—bone cancer	5.31e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—bone cancer	5.28e-06	0.000103	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSTP1—bone cancer	5.25e-06	0.000102	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL3—bone cancer	5.24e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSTP1—bone cancer	5.2e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—DHFR—bone cancer	5.2e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—DHFR—bone cancer	5.19e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GNA11—bone cancer	4.96e-06	9.69e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—DHFR—bone cancer	4.9e-06	9.57e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GNA11—bone cancer	4.86e-06	9.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GNA11—bone cancer	4.85e-06	9.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—bone cancer	4.84e-06	9.46e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTP1—bone cancer	4.77e-06	9.31e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.7e-06	9.18e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GNA11—bone cancer	4.58e-06	8.94e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP3A4—bone cancer	4.5e-06	8.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—DHFR—bone cancer	4.49e-06	8.77e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFBR2—bone cancer	4.48e-06	8.75e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP3A4—bone cancer	4.4e-06	8.6e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP3A4—bone cancer	4.39e-06	8.58e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—bone cancer	4.32e-06	8.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—bone cancer	4.22e-06	8.24e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1R—bone cancer	4.22e-06	8.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GNA11—bone cancer	4.2e-06	8.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP3A4—bone cancer	4.15e-06	8.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.13e-06	8.07e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—bone cancer	4.11e-06	8.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—DHFR—bone cancer	4.01e-06	7.83e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—bone cancer	3.97e-06	7.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—bone cancer	3.94e-06	7.7e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—DHFR—bone cancer	3.91e-06	7.64e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTP1—bone cancer	3.84e-06	7.51e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP3A4—bone cancer	3.81e-06	7.43e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.79e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTP1—bone cancer	3.77e-06	7.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTP1—bone cancer	3.76e-06	7.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GNA11—bone cancer	3.75e-06	7.32e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—DHFR—bone cancer	3.69e-06	7.2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GNA11—bone cancer	3.66e-06	7.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—DHFR—bone cancer	3.66e-06	7.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTP1—bone cancer	3.55e-06	6.94e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNA11—bone cancer	3.45e-06	6.73e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNA11—bone cancer	3.42e-06	6.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP3A4—bone cancer	3.4e-06	6.64e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.38e-06	6.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—bone cancer	3.37e-06	6.58e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP3A4—bone cancer	3.32e-06	6.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—bone cancer	3.26e-06	6.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP3A4—bone cancer	3.12e-06	6.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—DHFR—bone cancer	3.12e-06	6.1e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—bone cancer	3.1e-06	6.06e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP3A4—bone cancer	3.1e-06	6.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.08e-06	6.02e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—bone cancer	3.06e-06	5.97e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—bone cancer	2.99e-06	5.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNA11—bone cancer	2.92e-06	5.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—bone cancer	2.91e-06	5.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—bone cancer	2.87e-06	5.62e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—bone cancer	2.84e-06	5.54e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—bone cancer	2.72e-06	5.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—bone cancer	2.69e-06	5.26e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—bone cancer	2.67e-06	5.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—bone cancer	2.65e-06	5.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP3A4—bone cancer	2.65e-06	5.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.63e-06	5.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—bone cancer	2.6e-06	5.08e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—bone cancer	2.47e-06	4.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—DHFR—bone cancer	2.41e-06	4.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—bone cancer	2.41e-06	4.7e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—bone cancer	2.26e-06	4.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNA11—bone cancer	2.25e-06	4.4e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—bone cancer	2.09e-06	4.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—bone cancer	2.04e-06	3.98e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—bone cancer	1.99e-06	3.89e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—bone cancer	1.95e-06	3.81e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—bone cancer	1.95e-06	3.8e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—bone cancer	1.84e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—bone cancer	1.75e-06	3.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—bone cancer	1.69e-06	3.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—bone cancer	1.65e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—bone cancer	1.51e-06	2.94e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—bone cancer	1.47e-06	2.87e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—bone cancer	1.38e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—bone cancer	1.38e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—bone cancer	1.37e-06	2.68e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—bone cancer	1.17e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—bone cancer	9.05e-07	1.77e-05	CbGpPWpGaD
